A Babbott Pharmaceuticals (NYSE:ABB) stock was recently traded at $13.26, a price that is well above its close price of $11.94 on Tuesday.
Babbot Pharmaceuticals stock was one of the first cryptocurrencies to go public and gained more than 40% over the past two years.
Shares of the company are up more than 80% in 2017.
However, the stock has fallen by more than half since the start of 2017, losing nearly 90% of its value in 2017, according to Bloomberg News.
The company has lost more than $40 billion in market value.
It has struggled to turn a profit, with the company filing for Chapter 11 bankruptcy protection in April 2018.
Babbot’s shares have lost about 60% of their value since 2017.
In May, Babbatt announced that it would not be able to keep its $1.8 billion investment in Turing Pharmaceuticals Inc., which is a unit of the biopharmaceutical company BSKY.
The two companies have been trading at a loss since February 2017, when Turing was trading at around $12.50 per share.
The Turing acquisition came after Babbett announced it would invest $1 billion in the startup in 2018.
A total of $400 million was pledged by Babbitt in June.
However, Turing is now valued at $1,939 per share, according with Bloomberg.